Benefits of Weight-Loss Medications in Treating Obesity and Diabetes
The article discusses the potential benefits of weight-loss medications like Ozempic and Wegovy in treating obesity and diabetes. It also highlights the importance of addressing obesity early to prevent disease progression and reduce the risk of chronic illnesses.
Key Points
- GLP-1 agonists like Ozempic and Wegovy are intended to treat type 2 diabetes and obesity.
- Only 3% of eligible adults have received a prescription for weight-loss medications.
- Patients with a BMI over 27 may have insurance coverage for weight-loss medications.
Pros
- Weight-loss medications like Ozempic and Wegovy have been linked to additional benefits such as reducing heart disease and dementia risk.
- Treating obesity early can prevent disease progression and reduce the risk of major cardiovascular events.
- GLP-1 agonists have been shown to reduce the progression from prediabetes to type 2 diabetes by 94%.
Cons
- Some side effects of weight-loss medications include gastrointestinal issues like nausea, vomiting, constipation, and diarrhea.
- Patients with a family history of medullary thyroid cancer or pancreatitis should avoid these medications.
- Pregnant women are advised against taking weight-loss medications.